Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling (Q46963835)

26 December 2017

title

Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling (English)

1 reference

26 December 2017

author name string

Brian E Collins

1 reference

26 December 2017

Brian A Smith

1 reference

26 December 2017

Per Bengtson

1 reference

26 December 2017

James C Paulson

1 reference

26 December 2017

language of work or name

English

0 references

publication date

20 December 2005

1 reference

26 December 2017

published in

Nature Immunology

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

199-206

1 reference

26 December 2017

B cell signaling. Introduction

cites work

1 reference

CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction

21 January 2018

1 reference

CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.

21 January 2018

1 reference

Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.

21 January 2018

1 reference

CD22 is a negative regulator of B-cell receptor signalling

21 January 2018

1 reference

Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies

21 January 2018

1 reference

Hyperresponsive B cells in CD22-deficient mice

21 January 2018

1 reference

CD22 regulates thymus-independent responses and the lifespan of B cells.

21 January 2018

1 reference

CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.

21 January 2018

1 reference

Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22

21 January 2018

1 reference

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

21 January 2018

1 reference

Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection

21 January 2018

1 reference

Inhibition of the B cell by CD22: a requirement for Lyn

21 January 2018

1 reference

Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis

21 January 2018

1 reference

Visualization of negative signaling in B cells by quantitative confocal microscopy.

21 January 2018

1 reference

Regulation of lymphocyte activation by the cell-surface molecule CD22

21 January 2018

1 reference

CD22 associates with the human surface IgM-B-cell antigen receptor complex

21 January 2018

1 reference

Siglecs in innate immunity

21 January 2018

1 reference

Siglecs in the immune system

21 January 2018

1 reference

Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily

21 January 2018

1 reference

Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding

21 January 2018

1 reference

Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.

21 January 2018

1 reference

Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence

21 January 2018

1 reference

Immune regulation by the ST6Gal sialyltransferase

21 January 2018

1 reference

Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking

21 January 2018

1 reference

Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes

21 January 2018

1 reference

Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling

21 January 2018

1 reference

Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling

21 January 2018

1 reference

The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.

21 January 2018

1 reference

CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms

21 January 2018

1 reference

Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.

21 January 2018

1 reference

Molecular interactions regulate BCR signal inhibition by CD22 and CD72

21 January 2018

1 reference

Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization

21 January 2018

1 reference

Plasticity of B cell receptor internalization upon conditional depletion of clathrin

21 January 2018

1 reference

Lipid rafts and B-cell activation

21 January 2018

1 reference

The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens

21 January 2018

1 reference

The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts

21 January 2018

1 reference

The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction

21 January 2018

1 reference

Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes.

21 January 2018

1 reference

Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein

21 January 2018

1 reference

Association of CD22 with the B cell antigen receptor

21 January 2018

1 reference

7 January 2021

Siglecs--the major subfamily of I-type lectins

1 reference

7 January 2021

Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22

1 reference

7 January 2021

Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus

1 reference

7 January 2021

Reduction of marginal zone B cells in CD22-deficient mice

1 reference

7 January 2021

Expression of caveolin-1 in lymphocytes induces caveolae formation and recruitment of phosphofructokinase to the plasma membrane

1 reference

7 January 2021

Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin

1 reference

7 January 2021

Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background

1 reference

7 January 2021

Identifiers

DOI

10.1038/NI1283

1 reference

26 December 2017

Dimensions Publication ID

1040308585

0 references

1 reference

26 December 2017